Martha Roby Weekly Column: A Pro-Life Update from the Federal Level

0

Throughout my time in Congress, I have been staunchly and unapologetically pro-life. I will continue to use this platform to fight for life at every stage, because unborn babies cannot fight for themselves. Since much of the news in our state and throughout the country lately has focused on recent pro-life efforts, I would like to take this opportunity to share an update about my work on the federal level to defend the unborn.

In February of this year, the Trump Administration’s Department of Health and Human Services issued a rule that would restrict Title X family planning grants from being steered to entities that are not physically and financially separate from abortion providers. A series of court injunctions have frozen these rule changes, and as a result, hundreds of abortion facilities, like Planned Parenthood, are still receiving federal tax dollars through Title X grants.

While the rule is going through the judicial process, the Democrat majority on the House Appropriations Committee has elected to tie the hands of the Department of Health and Human Services through legislation stating that the Department may only act in accordance with regulations established prior to January 18, 2017, just two days before Donald Trump became President. This is unacceptable – we simply cannot handcuff the current Administration to regulations of the past.

During the recent full Appropriations Committee markup of the Labor, Health and Human Services, and Education Subcommittee Fiscal Year 2020 funding bill, I offered an amendment that would allow the courts, rather than the Democrat majority in the House, to decide the fate of the Trump Administration’s proposed rule restricting Title X family planning grants from being awarded to facilities that provide abortions. Despite the inclusion of the Hyde Amendment, abortion providers have been able to get their hands on American tax dollars through these Title X funds. I am unapologetically pro-life, so I don’t want this to happen, and the majority of the people I represent don’t want this to happen.

The Trump Administration’s proposed rule would draw a clear, bright line between family planning services and abortion providers. Unfortunately, my amendment did not pass, but to ensure that the rule has a fighting chance of becoming law, we must allow it to go through our judicial process – not block it legislatively as part of a political game.

In addition to the Department of Health and Human Services, the Food and Drug Administration (FDA) is also taking measures to stand up for the unborn. Two foreign companies, Aid Access and Rablon, have been known to distribute chemical abortion drugs to customers in the United States by mail-order. This practice is already illegal, and the FDA has taken action against it, but it is still happening.

This abortion drug, called Mifeprex, is approved by the FDA, but it is only legally available to patients in the United States through health care providers. It is not available in retail pharmacies, and it is certainly not legally available on the Internet. However, these abortion-by-mail providers, primarily based in Europe, have widened their consumer base to include the U.S. They provide remote consultations, send prescriptions to be filled in India, then send the abortion drug to U.S. customers by mail.

By violating the FDA’s safety protocols, these companies are endangering the health of American women and their children. The FDA has been combating these practices, but I recently led a letter, signed by 117 of my colleagues, that was sent to Dr. Norman Sharpless, Acting FDA Commissioner, urging him to further crack down. I was proud to join my fellow pro-life colleagues in sending the clear message that we will not tolerate these dangerous, illegal practices, and I applaud the steps the FDA has already taken to protect women and unborn children.

I share these updates to make the point that while we still face challenges, our pro-life momentum is strong, and I will keep pushing forward on the federal level. I want the people I represent in Alabama’s Second District to know that defending the unborn remains a top priority of mine, and I will continue to speak out for those who cannot speak for themselves.

Martha Roby represents Alabama’s Second Congressional District. She lives in Montgomery, Alabama, with her husband Riley and their two children.

Share.

Comments are closed.

Show Buttons
Hide Buttons
%d bloggers like this: